Clover Health (CLOV) PT Raised to $9 at Credit Suisse
Tweet
Share
E-mailGet Alerts CLOV Hot Sheet
Price: $4.30 --0%
Rating Summary:
2 Buy, 4 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
2 Buy, 4 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Credit Suisse analyst Jonathan Yong raised the price target on Clover Health (NASDAQ: CLOV) to $9.00 (from $8.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- MiniMed Group (MMED) PT Raised to $27 at StoneX on Conservative Revenue Guide
- Credo Tech (CRDO) PT Lowered to $310 at JPMorgan, Overweight Rating Maintained
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
